| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/24/2013 | CN102311928B Recombinant yeast engineering strain coexpressed by proteins of chicken anaemia viruses VP1 and VP2, construction method thereof and application thereof |
| 04/24/2013 | CN102309454B Preparation method of econazole nitrate/polyacrylic resin cationic nanoparticles |
| 04/24/2013 | CN102302711B Capsules for clearing away damp toxin |
| 04/24/2013 | CN102293912B Chinese medicine for treating pneumonia |
| 04/24/2013 | CN102276700B Swine hepatitis E virus antigen epitope and application thereof |
| 04/24/2013 | CN102274382B External Chinese medicinal material mixture for treating onychomycosis and whitlow |
| 04/24/2013 | CN102274218B Faropenem sodium and sulbactam sodium combined medicine |
| 04/24/2013 | CN102268078B Swine hepatitis E virus antigen epitope and application thereof |
| 04/24/2013 | CN102258595B Traditional Chinese medicine composition for treating tuberculosis, preparation and application thereof |
| 04/24/2013 | CN102258580B Macleaya cordata total alkaloid preparation method |
| 04/24/2013 | CN102240404B Vibrio harveyi DNA vaccine and its construction method and application |
| 04/24/2013 | CN102228686B Process for preparing veterinary rabies inactivated and freeze-dried vaccine through suspension culture cell |
| 04/24/2013 | CN102225902B Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 04/24/2013 | CN102218047B Medicament for treating drug-resistant bacteria infection, and application of active ingredient thereof in pharmacy |
| 04/24/2013 | CN102212520B Small interfering RNA (siRNA) sequence for specifically silencing chicken Marek's disease virus gI and gE genes, vectors and application thereof |
| 04/24/2013 | CN102206646B Mytilus etilus Hydramacin-1 gene, its recombination protein and preparation method |
| 04/24/2013 | CN102199205B Synthetic method of polypeptide thymosin alpha1 |
| 04/24/2013 | CN102174091B Truncated and expressed duck plague virus (DPV) recombinant envelope gI protein and preparation method and application thereof |
| 04/24/2013 | CN102160870B Application of poly(4-styrenesulfonic acid-co-maleic acid) sodium and medicinal composition thereof |
| 04/24/2013 | CN102146062B Thiazolidine neuraminidase inhibitor and application thereof |
| 04/24/2013 | CN102125533B Pazufloxacin mesylate tablet and preparation method and detection method thereof |
| 04/24/2013 | CN102100677B Entecavir dispersible tablets and preparation method thereof |
| 04/24/2013 | CN102031278B Method for enzymatic synthesis of trehalose unsaturated fatty acid diester in organic phase |
| 04/24/2013 | CN102018754B Vaginal effervescent tablet and making process thereof |
| 04/24/2013 | CN102015710B Azatricyclic antibiotic compounds |
| 04/24/2013 | CN102006865B Use of chemical compounds in preparing pharmaceutical composition for attenuating or inhibiting virus infection of flaviviruses |
| 04/24/2013 | CN101993869B Relevant experimental technique of epiphyte secondary metabolism function reformation and application thereof |
| 04/24/2013 | CN101993439B Lamivudine crystal form and preparation method thereof |
| 04/24/2013 | CN101991583B Anti-hepatitis C composition and method for preparing drugs for inhibiting hepatitis C virus or treating hepatitis C |
| 04/24/2013 | CN101979093B Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 04/24/2013 | CN101974073B Anti-inflammatory hexapeptide |
| 04/24/2013 | CN101959509B Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners |
| 04/24/2013 | CN101953872B Method for preparing Chinese medicinal preparation for treating influenza |
| 04/24/2013 | CN101948403B New antibacterial compound |
| 04/24/2013 | CN101905018B Recombinant fusion protein vaccine and attenuated live vector vaccine for treating and preventing helicobacter pylori (Hp) infection |
| 04/24/2013 | CN101861387B Novel bacteriophage and antibacterial composition containing the same |
| 04/24/2013 | CN101809009B New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections |
| 04/24/2013 | CN101798337B Mutant of endotoxin neutralizing peptide and application thereof |
| 04/24/2013 | CN101757178B Medicament composition for treating chronic hepatitis and preparation method thereof |
| 04/24/2013 | CN101720325B Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| 04/24/2013 | CN101643789B RNA interference mediating small RNA molecules |
| 04/24/2013 | CN101541784B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 04/24/2013 | CN101501049B Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 04/24/2013 | CN101485647B Use of patchouli alcohol in preparing medicament |
| 04/24/2013 | CN101450056B New use of sodium ion channel blocker in treating biology drug resistance of antibiotic |
| 04/24/2013 | CN101410519B Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 04/24/2013 | CN101367749B A set of mesidino mesitoyl derivant, preparation and application thereof |
| 04/24/2013 | CN101208297B Antiviral compounds and methods |
| 04/24/2013 | CN101208103B 免疫原性组合物 The immunogenic composition |
| 04/23/2013 | US8426426 Gyrase inhibitors and uses thereof |
| 04/23/2013 | US8426359 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/23/2013 | US8426167 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 04/23/2013 | US8425996 Indicators for detecting the presence of metabolic byproducts from microorganisms |
| 04/23/2013 | US8425939 Remedy |
| 04/23/2013 | US8425936 Antibiotic product, use and formulation thereof |
| 04/23/2013 | US8425917 Mutant forms of EtxB and CtxB and their use as carriers |
| 04/23/2013 | US8425896 Treatment of tumors with recombinant interferon alpha |
| 04/23/2013 | US8425894 Use of oligomers of lactic acid in the treatment of gynaecological disorders |
| 04/23/2013 | CA2577415C Enhancement of antitubercular activity of extracts of salicornia brachiata |
| 04/23/2013 | CA2571558C Novel uses of porphyrin compounds |
| 04/23/2013 | CA2557989C Sulfated oligosaccharide derivatives |
| 04/23/2013 | CA2541971C Herbal extracts of salicornia species, process of preparation thereof, use thereof against tuberculosis |
| 04/23/2013 | CA2515761C Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 04/23/2013 | CA2475102C Stabilized synthetic immunogen delivery systems |
| 04/23/2013 | CA2451637C Liver engrafting cells, assays, and uses thereof |
| 04/23/2013 | CA2416761C Method for screening peptides for use in immunotherapy |
| 04/21/2013 | CA2851104A1 Methods for treating hcv |
| 04/21/2013 | CA2811250A1 Methods for treating hcv |
| 04/21/2013 | CA2811203A1 Methods for treating hcv |
| 04/18/2013 | WO2013056163A1 Beta-lactamase inhibitors |
| 04/18/2013 | WO2013056079A1 High affinity beta lactamase inhibitors |
| 04/18/2013 | WO2013056046A1 Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| 04/18/2013 | WO2013056003A2 Catechol diethers as potent anti-hiv agents |
| 04/18/2013 | WO2013055825A2 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 04/18/2013 | WO2013055563A1 Compounds for the treatment of hepatitis c |
| 04/18/2013 | WO2013055540A1 Non-chemotherapeutic antibiotic treatment for infections in cattle |
| 04/18/2013 | WO2013055252A1 Salts of carbamoyl phosphonic acid esters which act as selective inhibitors of human immunodeficiency virus hiv-1 production |
| 04/18/2013 | WO2013054866A1 Agent for preventing or treating htlv-i associated myelopathy |
| 04/18/2013 | WO2013054862A1 Polycyclic pyridone derivative having integrase-inhibiting activity |
| 04/18/2013 | WO2013054275A1 Sila analogs of oxazolidinone derivatives and synthesis thereof |
| 04/18/2013 | WO2013053942A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances |
| 04/18/2013 | WO2013053658A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 04/18/2013 | WO2013053657A1 Antiviral compounds |
| 04/18/2013 | WO2013053428A1 Alloy and mammary gland insert for treating mastitis |
| 04/18/2013 | WO2013053372A1 Boronic acid inhibitors of beta-lactamases |
| 04/18/2013 | WO2012178036A3 Inhibitors of rtt109 as anti-fungal agents |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096090 Transition metal complexes of amino acids and related ligands and their use as catalysts, anti-microbials, and anti-cancer agents |
| 04/18/2013 | US20130096073 Casein Derived Peptides And Uses Thereof |
| 04/18/2013 | US20130095498 Novel group b streptococcus antigens |
| 04/18/2013 | US20130095188 Method of Encapsulating a Material Using Solvent Removal Technique, and Microspheres/Nanospheres/Matrix Made Therefrom Having Sustained Release Properties |
| 04/18/2013 | US20130095176 Controlled release drug delivery compostion |
| 04/18/2013 | US20130095163 Foaming formulations and cleansing products including silicone polyesters |
| 04/18/2013 | US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 04/18/2013 | US20130095065 Methods for Treating Vascular Leak Syndrome and Cancer |
| 04/18/2013 | US20130095063 Compounds for the Treatment of Hepatitis C |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | CA2851516A1 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 04/18/2013 | CA2851218A1 Polycyclic pyridone derivative having integrase-inhibiting activity |
| 04/18/2013 | CA2850439A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents |